These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 8445747)

  • 21. Essential thrombocythemia following polycythemia vera: an unusual sequence.
    Randi ML; Barbone E; Zerbinati P; Soini B; Rossi C; Girolami A
    J Med; 1996; 27(5-6):363-8. PubMed ID: 9151204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurologic manifestations of polycythemia vera. Analysis of 24 cases and review of the literature].
    Corredoira Sánchez JC; González López M; Cortés Laiño JA; Gomara García S; Pérez Alvarez R; Casariego Vales B; López Alvarez MJ; García Rodríguez JF
    An Med Interna; 1990 Feb; 7(2):67-70. PubMed ID: 2103237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The polycythemias].
    Clément F
    Schweiz Med Wochenschr; 1981 Aug; 111(33):1196-201. PubMed ID: 7280628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased free protein S levels in polycythemia vera.
    Loppi M; Furlan M; Brun del Re G; Wuillemin W; Lämmle B
    Thromb Haemost; 1990 Aug; 64(1):177-8. PubMed ID: 2148846
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosis of polycythemia vera in an anemic patient.
    Hassoun H; Pavlovsky M; Mansoor S; Stopka T
    South Med J; 2000 Jul; 93(7):710-2. PubMed ID: 10923962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative blood product administration and thromboembolic events in patients with treated polycythemia vera: a case-control study.
    Weingarten TN; Hofer RE; Ahle BJ; Kemp KM; Nkwonta JA; Narr BJ; Pardanani A; Schroeder DR; Sprung J
    Transfusion; 2015 May; 55(5):1090-7. PubMed ID: 25727411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characteristics of diagnostic approach to erythrocytosis of different genesis].
    Ter Arkh; 2012; 84(4):29-35. PubMed ID: 22774487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheological study on vascular occlusion and cellular hyperviscosity syndrome in polycythemia vera.
    Fujioka S
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):688-95. PubMed ID: 2618545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polycythemia vera: clinical aspects and course in 86 patients].
    Egli F; Wieczorek A; Niemöller M; Rhyner K
    Schweiz Med Wochenschr; 1988 Dec; 118(52):1969-75. PubMed ID: 3217777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients.
    Bachleitner-Hofmann T; Grumbeck E; Gisslinger H
    Thromb Res; 2003; 112(4):229-32. PubMed ID: 14987916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis.
    Bucalossi A; Marotta G; Bigazzi C; Galieni P; Dispensa E
    Am J Hematol; 1996 May; 52(1):14-20. PubMed ID: 8638606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia.
    Passamonti F; Rumi E; Pungolino E; Malabarba L; Bertazzoni P; Valentini M; Orlandi E; Arcaini L; Brusamolino E; Pascutto C; Cazzola M; Morra E; Lazzarino M
    Am J Med; 2004 Nov; 117(10):755-61. PubMed ID: 15541325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Bcl-x in erythroid precursors from patients with polycythemia vera.
    Silva M; Richard C; Benito A; Sanz C; Olalla I; Fernández-Luna JL
    N Engl J Med; 1998 Feb; 338(9):564-71. PubMed ID: 9475763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fibrinolysis studied by an in vitro clot lysis test in polycythemia vera].
    Pósán E; Ujj G; Kiss A; Telek B; Rák K; Udvardy M
    Orv Hetil; 1996 Jan; 137(2):71-4. PubMed ID: 8721871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.
    Moliterno AR; Hankins WD; Spivak JL
    N Engl J Med; 1998 Feb; 338(9):572-80. PubMed ID: 9475764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycythemia vera and essential thrombocythemia in young patients.
    Frezzato M; Ruggeri M; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):11-7. PubMed ID: 8039752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood pressure and the prevalence of hypertension in polycythemia vera and secondary polyglobulia].
    Lüscher T; Vetter H; Heilmann E; Rhyner K; Grimm J; Keller E; Voss HM; Streuli RA; Studer A; Vetter W
    Schweiz Rundsch Med Prax; 1983 Mar; 72(12):388-95. PubMed ID: 6856565
    [No Abstract]   [Full Text] [Related]  

  • 38. Pulmonary hypertension in polycythemia vera.
    Nand S; Orfei E
    Am J Hematol; 1994 Nov; 47(3):242-4. PubMed ID: 7942794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should whole-body red cell mass be measured or calculated?
    Balga I; Solenthaler M; Furlan M
    Blood Cells Mol Dis; 2000 Feb; 26(1):25-31; discussion 32-6. PubMed ID: 10772873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulation after coronary artery surgery in patients with polycythemia vera: report of two cases.
    Oz BS; Asgun F; Akay HT; Kaya E; Kuralay E; Tatar H
    J Card Surg; 2007; 22(5):420-2. PubMed ID: 17803581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.